Diabetic Ketoacidosis Treatments

Find Diabetic Ketoacidosis Treatments

Diabetic Ketoacidosis (DKA) is a serious complication of diabetes that can develop quickly, often catching patients and families off guard. It occurs when the body lacks enough insulin to turn blood sugar into energy, forcing it to break down fat for fuel instead. This process releases acids called ketones, which can lead to symptoms like extreme thirst, nausea, confusion, and deep fatigue. For someone living with diabetes, DKA is a frightening experience that requires immediate attention, but it is also a well-understood medical emergency with a clear path to recovery. 

Treatment is vital to restore the body’s chemical balance. The goal is to lower high blood sugar levels safely, rehydrate the body, and stop the production of acidic ketones. Because DKA can range from mild to life-threatening, treatment is almost always administered in a hospital setting where medical teams can closely monitor vital signs. The specific approach depends on the severity of the acidosis and whether there is an underlying trigger, such as an infection or a missed insulin dose (Centers for Disease Control and Prevention, 2021). 

Overview of treatment options for Diabetic Ketoacidosis 

The management of DKA relies on a “three-pillar” approach: fluid replacement, electrolyte correction, and insulin therapy. These three elements work together to reverse the metabolic crisis. 

Unlike chronic diabetes management, which focuses on maintenance, treating DKA is an acute intervention designed to stabilize the patient within hours. Medical professionals typically start with fluids to treat dehydration before administering insulin. This order is crucial for safety. Once the immediate crisis is resolved, the focus shifts back to the patient’s routine diabetes management plan to prevent recurrence. 

Medications used for Diabetic Ketoacidosis 

While intravenous (IV) fluids are technically a medical supply, they are the first line of therapeutic intervention. Sterile saline solutions are administered immediately to replace the massive amount of fluid lost through excessive urination. Clinical experience suggests that adequate rehydration alone can begin to lower blood sugar levels before insulin is even started. 

The primary medication used to reverse DKA is short-acting insulin (often Regular insulin), administered intravenously. Unlike the subcutaneous shots taken at home, IV insulin allows for precise, minute-by-minute control of blood sugar levels. Doctors aim for a steady, gradual decline in glucose rather than a sudden drop. 

Alongside insulin, electrolyte replacement is essential. Potassium is the most critical medication in this category. During DKA treatment, insulin causes potassium to shift out of the blood and into the cells, which can cause blood levels to drop dangerously low. Therefore, potassium is almost always added to the IV fluids. Other electrolytes, such as phosphate or magnesium, may also be supplemented depending on lab results. If an underlying infection triggered the DKA, antibiotics will be prescribed concurrently (American Diabetes Association, 2023). 

How these medications work 

Insulin acts as a key that unlocks the body’s cells, allowing glucose (sugar) to enter and be used for energy. In DKA, the lack of insulin has forced the body to burn fat, producing acidic ketones as a byproduct. By introducing insulin, the body stops burning fat and switches back to using glucose. This stops the production of new ketones, allowing the blood’s acidity to return to normal. 

Fluids work by expanding the blood volume. This dilutes the concentration of sugar and stress hormones in the bloodstream and helps the kidneys flush out the excess sugar and ketones through urine. Electrolyte supplements do not treat the DKA itself but protect the heart and muscles. They maintain the delicate electrical balance of the body, which is often disrupted as fluids and insulin shift chemicals in and out of cells (MedlinePlus, 2022). 

Side effects and safety considerations 

DKA treatment is a careful balancing act with safety concerns. The main risk is hypoglycemia from rapid insulin action; to prevent this, dextrose is added to IV fluids once blood sugar drops, allowing insulin to continue clearing ketones safely.  

Another major concern is hypokalemia (low potassium), which risks heart arrhythmias and necessitates frequent, often hourly blood checks. In rare cases, overly rapid treatment can cause cerebral edema, especially in children, so strict protocols ensure a gradual decrease in blood sugar. 

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care. 

References 

  1. Centers for Disease Control and Prevention. https://www.cdc.gov 
  1. American Diabetes Association. https://diabetes.org 
  1. MedlinePlus. https://medlineplus.gov 
  1. Mayo Clinic. https://www.mayoclinic.org 

Medications for Diabetic Ketoacidosis

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Diabetic Ketoacidosis.

Found 10 Approved Drugs for Diabetic Ketoacidosis

MetFORMIN

Brand Names
Actoplus, Alogliptin, Dapagliflozin, Glipizide, Glumetza, Glyburide, Glyburide-MetFORMIN, Invokamet, Janumet, Jentadueto, Kazano, Linagliptin, Pioglitazole, Pioglitazone, Riomet, Saxagliptin, Segluromet, Sitagliptin, Synjardy, Trijardy, Xigduo, Zituvimet

MetFORMIN

Brand Names
Actoplus, Alogliptin, Dapagliflozin, Glipizide, Glumetza, Glyburide, Glyburide-MetFORMIN, Invokamet, Janumet, Jentadueto, Kazano, Linagliptin, Pioglitazole, Pioglitazone, Riomet, Saxagliptin, Segluromet, Sitagliptin, Synjardy, Trijardy, Xigduo, Zituvimet
ACTOPLUS MET is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use ACTOPLUS MET is not recommended to treat type 1 diabetes mellitus or diabetic ketoacidosis. ACTOPLUS MET is a combination of pioglitazone, a thiazolidinedione agonist of peroxisome proliferator receptor gamma, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use : Not recommended for treatment of type 1 diabetes or diabetic ketoacidosis. ( 1 )

Empagliflozin

Brand Names
Glyxambi, Jardiance

Empagliflozin

Brand Names
Glyxambi, Jardiance
GLYXAMBI is a combination of empagliflozin and linagliptin indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease [see Clinical Studies (1.

Levemir

Generic Name
Detemir

Levemir

Generic Name
Detemir
LEVEMIR is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Limitations of Use LEVEMIR is not recommended for the treatment of diabetic ketoacidosis. LEVEMIR is a long-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus ( 1 ). Limitations of Use: Not recommended for the treatment of diabetic ketoacidosis.

Tresiba

Generic Name
Degludec

Tresiba

Generic Name
Degludec
TRESIBA is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus. Limitations of Use Not recommended for the treatment of diabetic ketoacidosis. TRESIBA is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus ( 1 ). Limitations of Use:, Not recommended for the treatment of diabetic ketoacidosis.

Glimepiride

Brand Names
Duetact, Pioglitazone

Glimepiride

Brand Names
Duetact, Pioglitazone
DUETACT is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with a thiazolidinedione and sulfonylurea or who have inadequate glycemic control on a thiazolidinedione alone or a sulfonylurea alone. Important Limitations of Use Pioglitazone exerts its antihyperglycemic effect only in the presence of endogenous insulin. DUETACT should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. Use caution in patients with liver disease [see Warnings and Precautions.
Showing 1-5 of 10
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances